Literature DB >> 34823122

Quantitative analysis of spinal cord neuropathology in experimental autoimmune encephalomyelitis.

Emily Wuerch1, Manoj Mishra1, Helvira Melo1, Vincent Ebacher1, V Wee Yong2.   

Abstract

Multiple sclerosis is an inflammatory and neurodegenerative condition that is frequently modeled using experimental autoimmune encephalomyelitis (EAE). Current methods of EAE histology include imprecise qualitative assessments and time-consuming analyses of selected regions. With increasing interest in neuroprotective or reparative therapies, it is important that potential therapeutics are evaluated in EAE through quantitative neuropathology. We describe a quantitative whole slide imaging immunofluorescence method that allows longitudinal sections of the entire EAE thoracic spinal cord to be investigated for the extent of neuroinflammation, axonal loss, and myelin density. This method should impact MS research by making histological comparisons of EAE increasingly robust.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Analysis; EAE; Multiple sclerosis; Neuroinflammation; Neuropathology; Remyelination

Mesh:

Year:  2021        PMID: 34823122     DOI: 10.1016/j.jneuroim.2021.577777

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  2 in total

1.  Thermoregulatory dynamics reveal sex-specific inflammatory responses to experimental autoimmune encephalomyelitis in mice: Implications for multiple sclerosis-induced fatigue in females.

Authors:  Jamshid Faraji; Dennis Bettenson; Stella Babatunde; Tabitha Gangur-Powell; Voon Wee Yong; Gerlinde A S Metz
Journal:  Brain Behav Immun Health       Date:  2022-05-31

2.  A Distinct Hibiscus sabdariffa Extract Prevents Iron Neurotoxicity, a Driver of Multiple Sclerosis Pathology.

Authors:  Manoj Kumar Mishra; Jianxiong Wang; Reza Mirzaei; Rigel Chan; Helvira Melo; Ping Zhang; Chang-Chun Ling; Aldo Bruccoleri; Lin Tang; V Wee Yong
Journal:  Cells       Date:  2022-01-27       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.